Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society)

Ивашкин, В. Т.; Маев, И. В.; Tsarkov, Petr; Korolev, M P; Андреев, Д. Н.; Baranskaya, E. K.; Бурков, С. Г.; Derinov, A. A.; Efetov, Sergey; Лапина, Т. Л.; Павлов, П. В.; Пирогов, С. С.; Tkachev, Alexander; Трухманов, А. С.; Федоров, Е. Д.; Шептулин, А. А.

doi:10.22416/1382-4376-2020-30-1-49-70

Cited by 46 publications

(49 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В комплекс стандартной медикаментозной терапии входят АСК, НФГ или НМГ, статины, если позволяет гемодинамика -ББ и нитраты при наличии боли в груди [20,21].…”

Section: острый коронарный синдромunclassified

“…Пациентам, страдающим ОКС, при отсутствии противопоказаний следует немедленно назначить АСК (160-325 мг) без кишечнорастворимой оболочки, с последующим приемом в низкой дозе (80 мг) длительно. Ингибиторы P2Y 12 (клопидогрель, тикагрелор или прасугрел), двойная и тройная антиагрегантная терапия назначаются в соответствии с международными рекомендациями [21][22][23].…”

Section: острый коронарный синдромunclassified

“…Большая доказательная база, свидетельствующая об эффективности препарата в лечении различных заболеваний ЖКТ, нашла отражение во включении ребамипида в клинические рекомендации российских и международных врачебных ассоциаций [17][18][19][20][21][22].…”

Section: гастроэнтерологические проявления Covid-19unclassified

“…Язвенная болезнь (ЯБ) -хроническое, циклически рецидивирующее заболевание желудка и двенадцатиперстной кишки, полиэтиологическое (в большинстве случаев ассоциированное с инфекцией Н. pylori), морфологическими эквивалентами которого являются язвенный дефект и/или рубцовая деформация в пределах гастродуоденальной СО, манифестирующее характерным болевым абдоминальным, диспепсическим, регургитационным и астено-вегетативным синдромами, осложнениями которого могут быть кровотечение, перфорация, пенетрация, стенозирование и малигнизация [17,21].…”

Section: рекомендации по терапии пациентов с хроническим гастритом наunclassified

See 3 more Smart Citations

Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

Гриневич

Губонина

Doshchitsin

et al. 2020

Cardiovasc Ther Prev

View full text Add to dashboard Cite

The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in context of a pandemic requires a comprehensive approach aimed both at the optimal management in self-isolated patients not visiting medical facilities, and management of comorbidities in patients with COVID-19. The presented consensus covers these two aspects of managing patients with cardiovascular disease, diabetes, chronic obstructive pulmonary disease, gastrointestinal disease, and also pay attention to the multiple organ complications of COVID-19.

show abstract

Section: острый коронарный синдромunclassified

Section: гастроэнтерологические проявления Covid-19unclassified

Section: рекомендации по терапии пациентов с хроническим гастритом наunclassified

See 2 more Smart Citations

Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

Гриневич

Губонина

Doshchitsin

et al. 2020

Cardiovasc Ther Prev

View full text Add to dashboard Cite

show abstract

“…Вместе с тем в качестве возможных средств, повышающих эффективность эрадикационной терапии, рекомендуется прием лишь определенных пробиотиков [36]. Помимо этого, последние рекомендации РГА допускают использование цитопротектора -ребамипида при применении тройной терапии для повышения уровня эрадикации микроорганизма [37,38]. Эффективность такого подхода подтверждена недавним метаанализом [39].…”

Section: ðèñ 4 ñõåìû ýðàäèêàöèîííîé òåðàïèè íàçíà÷åííûå â êà÷åñòâåunclassified

European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan

Абдулхаков

Bordin

Абдулхаков³

et al. 2020

Terapevticheskii arkhiv

View full text Add to dashboard Cite

Background. As part of an observational multicenter prospective study European Registry on the management of Helicobacter pylori infection, conducted on the initiative of the European H. pylori and Microbiota Study Group, the compliance of clinical practice in the management of patients with Helicobacter pylori infection in Kazan with clinical guidelines was assessed. Materials and methods. The data of 437 patients included into the register by clinical sites in Kazan in 20132019 were analyzed. The methods used for the initial diagnosis of H. pylori infection and eradication control were evaluated. The frequency of various eradication therapy regimens prescription was analyzed in 379 cases. Data regarding the effectiveness of eradication therapy was analyzed in 173 patients. Results. The rapid urease test (44.2% of cases) and cytology/histology (60% of cases) were most often used for the initial diagnosis of H. pylori infection; however non-invasive methods such as 13C-urea breath (9.2%), serology (6.2%), H. pylori stool antigen test (2.3%) were less common. In 21.7% of patients two methods of H. pylori detection were used for primary diagnosis. The control test to evaluate the effectiveness of eradication therapy at the recommended timepoint was performed in 46.2% of patients. 13C-urea breath test (31.7%), stool PCR/stool antigen test (28.7%), rapid urease test (22.3%), cytology/histology (26.2% of cases) prevailed in the assessment of eradication rate. Standard triple therapy, including proton pump inhibitor, clarithromycin and amoxicillin was most commonly prescribed as first-line therapy (64.6% of cases). The duration of eradication therapy was 14 days in the majority of cases with pantoprazole as the most common proton pump inhibitor in standard triple therapy regimens (84.8%). The efficacy of 14-day standard triple therapy (mITT) was 87.0%. Conclusion. The results indicate a high frequency of non-invasive methods use for assessing the effectiveness of eradication therapy; however, the overall rate of eradication efficacy assessment is low, limiting the possibility of analyzing the eradication results. The effectiveness of the most common 14-day standard triple first-line therapy in Kazan doesnt reach the recommended 90% eradication level. This could be explained by high rate of pantoprazole use, which is not an optimal proton pump inhibitor in eradication therapy regimens.

show abstract

Analysis of staged treatment and some socio-hygienic and biological factors for the onset and course of gastric ulcer and duodenal ulcer

Tukhtaev

Tukhtaeva²

2021

E3S Web Conf.

View full text Add to dashboard Cite

In a social-hygienic study, some factors influencing the occurrence and dynamics of the course of gastric ulcer and duodenal ulcer in 379 patients were studied. The results of the data show that the complete staged treatment (polyclinic, hospital, sanatorium) is not carried out for all patients (24.3%) for the entire study period. In the first year of the disease, it was carried out in only 6.8% of patients. To determine the strength of the influence of some socio-hygienic and biological factors on the dynamics of the course of peptic ulcer disease, we used the method of analysis of variance. The analysis of the dynamics of gastric ulcer and duodenal ulcer with the calculation of a static assessment, which reliability is quite convincing, made it possible to conclude with maximum reliability that the dynamics of the disease, in addition to surgical treatment 45.1% (with complications in the form), is most strongly influenced by the nutrition factor 8.5% ... The effect of other factors is approximately the same: material housing conditions 6.6%, the psychological factor 6.5% and working conditions 4.5%.

show abstract

Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society)

Cited by 46 publications

References 45 publications

Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan

Analysis of staged treatment and some socio-hygienic and biological factors for the onset and course of gastric ulcer and duodenal ulcer

Contact Info

Product

Resources

About